poloxamine 908, 11111-34-5

Articles:

PubMed:Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.

PubMed:Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumour growth.

PubMed:Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering.

PubMed:Modification of the Stewart biphasic colorimetric assay for stable and accurate quantitative determination of Pluronic and Tetronic block copolymers for application in biological systems.

PubMed:Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays.

PubMed:Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption.

PubMed:[Development and estimation of nanosomal rifampicin].

PubMed:Differences in the adsorption behaviour of poly(ethylene oxide) copolymers onto model polystyrene nanoparticles assessed by isothermal titration microcalorimetry correspond to the biological differences.

PubMed:A topical w/o/w multiple emulsions prepared with Tetronic 908 as a hydrophilic surfactant: formulation, characterization and release study.

PubMed:Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting.

PubMed:Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN).

PubMed:Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages-impact of phagocytosis on viability and cytokine production.

PubMed:Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908.

PubMed:Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.

PubMed:Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models.

PubMed:Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.

PubMed:Recognition and clearance of methoxypoly(ethyleneglycol)2000-grafted liposomes by macrophages with enhanced phagocytic capacity. Implications in experimental and clinical oncology.

PubMed:Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages.

PubMed:Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation.

PubMed:Re-establishing the long circulatory behaviour of poloxamine-coated particles after repeated intravenous administration: applications in cancer drug delivery and imaging.

PubMed:Influence of the surfactant concentration on the body distribution of nanoparticles.

PubMed:Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS.

PubMed:Physical stability of ethyl diatrizoate nanocrystalline suspension in steam sterilization.

PubMed:Cloud point of nonionic surfactants: modulation with pharmaceutical excipients.

PubMed:In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres.

PubMed:Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres.

PubMed:Activation of the mononuclear phagocyte system by poloxamine 908: its implications for targeted drug delivery.

PubMed:A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats.

PubMed:Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.

PubMed:Prolonging the circulation time and modifying the body distribution of intravenously injected polystyrene nanospheres by prior intravenous administration of poloxamine-908. A 'hepatic-blockade' event or manipulation of nanosphere surface in vivo?

PubMed:Human serum albumin as a probe for surface conditioning--a study of the ageing effect.

PubMed:Poly(organo phosphazene) nanoparticles surface modified with poly(ethylene oxide).

PubMed:Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.

PubMed:Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution.

PubMed:Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats.

PubMed:Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum.

PubMed:An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen.

PubMed:Effect of splenic congestion associated with haemolytic anaemia on filtration of 'spleen-homing' microspheres.

PubMed:Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake.

PubMed:Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly(methyl methacrylate) nanoparticles.

PubMed:The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908.

poloxamine 908
methyl oxirane polymer with oxirane/ether with (1,2-ethane diyl dinitrilo)tetrakis(propanol)(2;122)

Supplier Sponsors

Articles:

poloxamine 908 methyl oxirane polymer with oxirane/ether with (1,2-ethane diyl dinitrilo)tetrakis(propanol)(2;122)

Supplier Sponsors

Articles:

poloxamine 908
methyl oxirane polymer with oxirane/ether with (1,2-ethane diyl dinitrilo)tetrakis(propanol)(2;122)